Intra-cellular therapies to present at the 42nd annual j.p. morgan healthcare conference

New york, jan. 02, 2024 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced that sharon mates, ph.d., chief executive officer and chairman, is scheduled to present at the 42nd annual j.p. morgan healthcare conference on tuesday, january 9, 2024 at 8:15 a.m. pt in san francisco, ca.
ITCI Ratings Summary
ITCI Quant Ranking